The National Pharmaceuticals Pricing Authority (NPPA) on October 25, 2023, issued a notification regarding the fixation of the retail price particular firm for approval under the Drugs (Price Control) Order, 2013.
The following has been stated namely: -
· M/s Cadila Pharmaceuticals Limited shall inform NPPA, of the date of commercial marketing of the formulation “Cholecalciferol Aqueous Injection 6,00,000 IU/2ml (Vitamin D3 Injection)” in the country and the Price to Retailer (PTR) and Maximum Retail Price fixed by the company in respect of above said formulation by issuing a price list in Form V under DPCO, 2013.
· M/s Cadila Pharmaceuticals Limited shall also seek retail price approval for the formulation “Cholecalciferol Aqueous Injection 6,00,000 IU/2ml (Vitamin D3 Injection)”, if applicable, three months before the expiry of the exemption granted under Para 32(i)& 32 (ii) of DPCO 2013.
[Notification No. S.O. 4662(E)]
